Superbug Resistance Spreads to Every Region

A comprehensive global analysis spanning 82 countries from 2004 to 2022 reveals a worrying surge in antibiotic resistance across all regions. Researchers from the Murdoch Children's Research Institute and the University of Sydney analyzed over 106,000 infection samples from children, finding that bacteria are increasingly evading antimicrobial treatments.

Children in intensive care and those in nations with fewer healthcare resources are disproportionately affected. Severe infections like sepsis and pneumonia, often caused by resilient bacteria such as Acinetobacter baumannii and Klebsiella, are driving this increase. Notably, Klebsiella has shown the fastest rise in resistance, especially in Southeast Asia, Eastern Europe, and the Western Pacific.

Statistical modeling predicts a substantial rise in resistance to last-line antibiotics by 2035, potentially reaching 82% for Acinetobacter baumannii and 35% for Klebsiella. This escalating threat, largely overlooked in child-focused research, necessitates better surveillance and child-friendly treatment guidelines.

The study's findings, published in the Journal of the American Medical Association, highlight that while first-line antibiotic resistance is stabilizing in high-income regions, lower-resource settings face a sharp increase in resistance to critical antibiotics. This underscores the urgent need for global surveillance systems to track and combat emerging resistance patterns.